Genetics of hyperuricemia and gout: implications for the present and future (Q38073215)

28 August 2017

1 reference

title

Genetics of hyperuricemia and gout: implications for the present and future (English)

1 reference

28 August 2017

Ronald L George

1

1 reference

28 August 2017

Robert T Keenan

series ordinal

2

1 reference

28 August 2017

publication date

1 February 2013

1 reference

Current Rheumatology Reports

28 August 2017

published in

1 reference

28 August 2017

volume

15

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

309

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-012-0309-8

28 August 2017

exact match

0 references

cites work

Loss of urate oxidase activity in hominoids and its evolutionary implications

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Genetic control of the renal clearance of urate: a study of twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Segregation analysis of serum uric acid in the NHLBI Family Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency in Gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Hereditary interstitial kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Identification of low-frequency variants associated with gout and serum uric acid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Characterization of the enzymatic defect in late-onset muscle phosphofructokinase deficiency. New subtype of glycogen storage disease type VII

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

ATP degradation products after ischemic exercise: hereditary lack of phosphorylase or carnitine palmityltransferase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

The genetic basis of hyperuricaemia and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Urate transport across the apical membrane of renal proximal tubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Uric acid transport and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Mutational analysis of idiopathic renal hypouricemia in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

High-resolution melting analysis for the rapid detection of an intronic single nucleotide polymorphism in SLC22A12 in male patients with primary gout in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Facilitative glucose transporter 9, a unique hexose and urate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Identification of a new member of type I Na/phosphate co-transporter in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Substrate overlap between Mrp4 and Abcg2/Bcrp affects purine analogue drug cytotoxicity and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Decreased extra-renal urate excretion is a common cause of hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Gout. Novel therapies for treatment of gout and hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Genotype-based changes in serum uric acid affect blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Gout therapeutics: new drugs for an old disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Rescue of folding defects in ABC transporters using pharmacological chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

SLC2A9 influences uric acid concentrations with pronounced sex-specific effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Genome-wide association of serum uric acid concentration: replication of sequence variants in an island population of the Adriatic coast of Croatia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

A genome-wide association study of serum uric acid in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

SLC2A9 is a high-capacity urate transporter in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Multiple single nucleotide polymorphisms in the human urate transporter 1 (hURAT1) gene are associated with hyperuricaemia in Han Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

T6092C polymorphism of SLC22A12 gene is associated with serum uric acid concentrations in Korean male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

Correction of Defective Protein Kinesis of Human P-glycoprotein Mutants by Substrates and Modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0309-8

X-linkage does not account for the absence of father-son similarity in plasma uric acid concentrations

21 January 2018

1 reference

12 December 2020

Probenecid (benemid); its uses and side-effects in 2,502 patients

1 reference

12 December 2020

The heredity of gout and its relationship to familial hyperuricemia

1 reference

12 December 2020

Hyperuricemia in medium-chain acyl-coenzyme A dehydrogenase deficiency

1 reference

12 December 2020

Gout and its comorbidities.

1 reference

12 December 2020

Diagnostic tests for primary renal hypouricemia

1 reference

12 December 2020

Molecular identification of a renal urate anion exchanger that regulates blood urate levels

1 reference

12 December 2020

Gout in ambulatory care settings in the United States

1 reference

12 December 2020

Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII

1 reference

12 December 2020

Severe Hypersensitivity Reactions to Allopurinol

1 reference

12 December 2020

The SLC22A12 gene is associated with gout in Han Chinese and Solomon Islanders

1 reference

12 December 2020

Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population

1 reference

12 December 2020

Absence of SLC22A12/URAT1 gene mutations in patients with primary gout

1 reference

12 December 2020

Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008

1 reference

12 December 2020

10.1007/S11926-012-0309-8

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1024296170

0 references

1 reference